Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
J.B. Chemicals & Pharmaceuticals, commonly known as JB Pharma and historically operating under the name Unique Pharmaceutical Laboratories, is a prominent Indian pharmaceutical company with a strong global presence. The company specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical formulations, including branded generics and active pharmaceutical ingredients. It holds leading market positions in therapeutic segments such as hypertension, gastroenterology, and nephrology, with flagship brands like Cilacar and Rantac. JB Pharma is also recognized as one of the world's largest manufacturers of medicated lozenges, serving as a key contract manufacturing partner for global healthcare firms. Headquartered in Mumbai, the company operates multiple state-of-the-art manufacturing facilities and exports its products to over 40 countries. Since 2020, the company has been majority-owned by the global investment firm KKR, which has supported its continued expansion and portfolio diversification.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unique Chemicals.